Focusing our efforts at #BIO2024 to catalyze strategic collaborations around drug discovery and development: https://lnkd.in/em6Kqji5
Variant Bio
Biotechnology Research
Seattle, Washington 3,820 followers
People-Driven Therapeutics
About us
Variant Bio is developing therapies that will improve global health by studying the genes of people who are outliers for medically relevant traits.
- Website
-
http://www.variantbio.com
External link for Variant Bio
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Seattle, Washington
- Type
- Privately Held
- Founded
- 2018
Locations
-
Primary
188 E Blaine St
Suite 126
Seattle, Washington 98102, US
Employees at Variant Bio
Updates
-
It is an honor to see a case study from Variant Bio and research on gout carried out in French Polynesia featured in the latest report from Public Policy Projects: "Creating a More Equitable Genomics Ecosystem." Read more in the press release and download the full report here 👉 https://lnkd.in/djPv2Aun
-
-
Honored to be a part of the conversation at this year’s ELSI Congress, which focuses on the ethical, legal, and social implications (ELSI) of genomic research. Dialogue between industry and academia is key to reimagining — and materializing — the benefits of genomic science. #ELSIcon2024
-
-
Wonderful to be in conversation with bioethicists from around the world when presenting about Variant Bio’s approach to genomic research and drug discovery at this week’s World Congress of Bioethics in Doha, Qatar #WCB2024
-
-
Variant Bio reposted this
Seeing in person how an ongoing project in the Faroe Islands will lead to genomic findings and improve health: https://lnkd.in/eb6Dk_KA
A Visit with Partners in the Faroe Islands
medium.com
-
Seeing in person how an ongoing project in the Faroe Islands will lead to genomic findings and improve health: https://lnkd.in/eb6Dk_KA
A Visit with Partners in the Faroe Islands
medium.com
-
So fun to see a physical copy of our article that came out in Genome Research earlier this year! See the full open-access article here: https://lnkd.in/eUauYGs3
-
-
Olivia Gray, PhD from Variant Bio presenting at the Biology of Genomes conference this week about the important genomic resource that has resulted from one of our research collaborations in South Africa:
-
-
The importance of optimizing compounds’ design and determining the viability of drug candidates for use in humans: https://lnkd.in/gfTKxAmu
Spotlight on R&D: Inside the World of DMPK
medium.com
-
What does an ethics-first approach to genomic research and drug development look like? How can researchers do better? An interview with Sarah LeBaron von Baeyer, PhD -- cultural anthropologist and Director of Ethics & Engagement at Variant Bio.
This drug company not only shares results with the international communities they study, they share cash as well! Bravo. We talk today with Sarah LeBaron von Baeyer, PhD, an anthropologist at Variant Bio. https://lnkd.in/gVQ9NQ3n
An Ethics First to Genetic Research and Drug Development with Sarah LeBaron von Baeyer
mendelspod.com